Abstract

B cells can have a regulatory role, mainly mediated by interleukin 10 (IL-10). IL-10 producing B cells (B10 cells) cells remain to be better characterized. Annexin V binds phosphatidylserine (PS), which is externalized during apoptosis. Previous works suggested that B10 cells are apoptotic cells since they bind Annexin V. Others showed that Annexin V binding could also be expressed on viable B cells. We aimed to explore if PS exposure can be a marker of B10 cells and if PS exposure has a functional role on B cell IL-10 production in healthy subjects. We found that B10 cells were significantly more often Annexin V+ than IL-10 non-producing B cells. After CpG activation, Annexin V+ B cells differentiated more often into B10 cells than Annexin Vneg B cells. Cell death and early apoptosis were similar between Annexin V+ and Annexin Vneg B cells. PS blockage, using biotinylated AnV and glyburide, decreased B10 cell differentiation. This study showed that B10 cells have an increased PS exposure independently of any apoptotic state. B cells exposing PS differentiate more into B10 cells whereas PS blockage inhibits B10 cells generation. These results strongly suggest a link between PS exposure and B10 cells.

Highlights

  • B cells have a promoting role in auto-immune diseases, which is mediated by autoantibody production, antigen presenting functions and pro-inflammatory cytokine secretion

  • B10 cells were generated from Peripheral blood mononuclear cells (PBMCs) of 21 healthy subjects using the protocol for B10 cell assessment

  • annexin V (AnV) Median of fluorescent intensity (MFI) was higher in interleukin 10 (IL-10) producing B cells compared to IL-10neg B cells (Ann V MFI in B10neg cells: 91.7 (84.8–95.2)% of AnnV MFI in B10+ cells, p

Read more

Summary

Introduction

B cells have a promoting role in auto-immune diseases, which is mediated by autoantibody production, antigen presenting functions and pro-inflammatory cytokine secretion. B cells can have a negative regulatory role. These so-called regulatory B cells were originally identified in relevant inflammatory mouse models, including arthritis, by their ability to improve already established disease in transfer experiments [1,2]. The regulatory B cells are mainly characterized by their secretion of interleukin 10 (IL-10) and so are often called B10 cells. Several studies have implicated B10 cells as immunosuppressive drivers promoting malignancy progression [4]. IL-10 is overexpressed in human chronic lymphocytic leukemia (CLL) and human malignant CLL cells can produce autocrine IL-10 [5,6]. IL-10 is PLOS ONE | DOI:10.1371/journal.pone.0169755 January 10, 2017

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call